International Flavors & Fragrances Inc logo

International Flavors & Fragrances Inc(IFF)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
3-STAR RATING
STRONG BUY
BUY for 60 days
PROFIT SINCE LAST BUY
+3.42% ▲
LAST CLOSE
$90.66
10/28/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for IFF

10/28/2026: IFF (3-star) is a STRONG-BUY. BUY for 60 days. Simulated Profits (3.42%). Updated daily EoD!

International Flavors & Fragrances is a global leader that provides essential taste, scent, and bioscience ingredients to major consumer brands. The company possesses a strong market position and a deep intellectual property portfolio in high-growth areas like enzymes and probiotics. Its primary investment story hinges on successfully executing a portfolio optimization strategy to improve margins and reduce significant debt incurred from past large-scale acquisitions. Key risks include intense competition, raw material cost volatility, and the execution risk associated with ongoing integration efforts. It may best suit investors looking for long-term exposure to consumer staples, though they should monitor debt reduction progress and margin expansion trends closely.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitThe company is transitioning from a period of heavy acquisition-led growth to a phase of efficiency and margin improvement.
Momentum investorWeak fitThe stock has experienced extended volatility, necessitating a strong upturn signal to confirm positive momentum.
Value investorMixed fitThe valuation may look attractive depending on the success of deleveraging and margin expansion efforts.
Dividend investorStrong fit while signal remains positiveThe company has a consistent history of paying dividends and remains focused on returning capital to shareholders.
Low-risk investorWeak fitThe company's significant debt load and integration history contribute to a higher risk profile than more stable consumer staples.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMedium / highThe stock is susceptible to fluctuations based on integration progress and broader macro sentiment.
Valuation riskMediumInvestors must assess whether current price levels appropriately reflect the potential for future margin expansion.
Competition risk (specialty ingredients)HighIntense competition from Givaudan and dsm-firmenich limits pricing power in key segments.
Business qualityStrongThe company holds a strong market position and essential role in the supply chain for consumer giants.
Dividend incomeMedium / highThe dividend is supported by strong cash flows but requires disciplined balance sheet management.
Execution riskMedium / highSuccessful integration of massive past acquisitions is critical to realizing long-term shareholder value.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Moderately Choppy
PRICE STABILITY

Moderately Choppy

The stock has experienced noticeable price swings while retaining some directional structure.

Analysis of Past Performance

Type Stock
Historic Profit 15.87%
Avg. Invested days 55
Today’s Advisory Strong Buy
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 2.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 10/28/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
IFF receives a 3-star rating, supported by solid analyst coverage. The rating is constrained by soft unit economics, weak price momentum, and limited analyst upside.

Company Fundamentals

★★★★★
IFF has moderate overall fundamentals (3 stars), with moderate financial health, soft growth momentum, and solid ownership. In FY2025 versus FY2024, growth and ownership metrics are mixed: negative earnings growth (-248.6%), soft cash generation (FCF margin 2.4%), negative revenue growth (-5.2%).

Financial Health Rating

★★★★★
IFF's financial health is supported by moderate cash strength, including free-cash-flow generation (2.4% of revenue). Profitability is soft (2 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
IFF's growth profile is soft, with the least-weak measure being revenue growth at -5.2% FY2025 versus FY2024. By comparison, while earnings growth (-248.6%, negative) and free-cash-flow growth (-57.5%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 110.2% and approximately 99.7% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership is only 0.11%, which materially reduces the ownership score.

Top 5 Institutional Investors

Dodge & Cox 14.50%
Freemont Capital Pte Ltd 9.94%
BlackRock Inc 9.08%
Arnhold & S. Bleichroeder Advisers, LLC 7.38%
Vanguard Capital Management, LLC 6.37%

Unit Economics (Per $1K Revenue)

★★★★★
IFF generates approximately $362 of gross profit, $77 of operating income, and $24 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Soft margins explain the 2-star rating, with weak cash conversion and weak capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 12.86%

Quantitative Style Profile

★★★★★
IFF has a large-cap, liquid profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

Large / Mega Cap StabilityShort Squeeze RiskHighly Liquid / Institution-Friendly

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 23.78B USD
Price to earnings Ratio 92.29
1Y Target Price 97.47
Price to earnings Ratio 92.29
1Y Target Price 97.47
Volume (30-day avg) 2.0M shares
Beta 0.93
52 Weeks Range 59.97 - 94.65
Updated Date 10/28/2026
52 Weeks Range 59.97 - 94.65
Updated Date 10/28/2026
Dividends yield (FY) 1.71%
Basic EPS (TTM) 1.01

How Company Makes Money

Business areaWhat it includesRetail investor read
NourishFlavors, texture, and nutrition ingredients for global food and beverage brands.This is the company's largest segment, providing the essential tastes and textures for products you likely use daily.
ScentFragrances for perfumes, home care, and cleaning products.This segment creates the scents for high-end perfumes and everyday household cleaning items.
Health & BiosciencesEnzymes, cultures, and probiotics for health and industrial use.This is a high-tech segment focusing on innovative biological solutions for food and health.
Pharma SolutionsSpecialty excipients used in drug formulations.This provides critical components that help make medications and supplements work effectively.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2026-11-03
When After Market
Estimate 0.81
Actual -

Profitability

Profit Margin 2.57%
Operating Margin (TTM) 8.5%

Management Effectiveness

Return on Assets (TTM) 2.27%
Return on Equity (TTM) -5.55%

Valuation

Trailing PE 92.29
Forward PE 23.15
Enterprise Value 29.58B
Price to Sales(TTM) 2.21
Enterprise Value 29.58B
Price to Sales(TTM) 2.21
Enterprise Value to Revenue 2.74
Enterprise Value to EBITDA 64.72
Shares Outstanding 255.15M
Shares Floating 254.45M
Shares Outstanding 255.15M
Shares Floating 254.45M
Percent Insiders 0.11
Percent Institutions 110.22

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.